安彩高科(600207.SH):擬以2.12億元收購光熱科技100%股權
格隆匯9月7日丨安彩高科(600207.SH)公佈,公司擬收購控股股東河南投資集團有限公司持有河南安彩光熱科技有限責任公司(“光熱科技”)100%股權,交易金額為2.12億元,收購事項完成後,光熱科技將成為公司的全資子公司。
光熱科技具備超白浮法玻璃、光熱玻璃等高端玻璃生產能力,產品具有廣泛用途和良好的市場前景。公司收購光熱科技100%股權,有利於增強公司超白浮法玻璃、光熱玻璃等高端玻璃技術實力,擴大產品應用領域,提升公司競爭力,符合公司發展規劃。此次收購完成後,公司可以避免與光熱科技潛在的同業競爭。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.